HKEX to launch Hang Seng Biotech Index Futures
It will keep track of the 30 largest southbound Stock Connect-eligible biotech companies in HK.
Hong Kong Exchanges and Clearing Limited (HKEX) plans to launch Hang Seng Biotech Index Futures, which commences trading on 28 November 2025.
The index will track the performance of the 30 largest southbound Stock Connect-eligible biotech, pharmaceuticals and medical devices companies in Hong Kong.
It will offer investors a targeted risk management tool, complementing HKEX’s existing suite of biotech-related offerings and flagship equity index derivatives.